Reference
- Chen J, Mangelinckx S, Ma L, et al. (2014). Caffeoylquinic acid derivatives isolated from the aerial parts of Gynura divaricata and their yeast α-glucosidase and PTP1B inhibitory activity. Fitoterapia 99:1–6.
- Chen Q. (1994). Methodology on Chinese Medicinal Pharmacology. Beijing: People's Medical Publishing House.
- Danino O, Gottlieb HE, Grossman S, et al. (2009). Antioxidant activity of 1,3-dicaffeoylquinic acid isolated from Inula viscosa. Food Res Int 42:1273–80.
- Dicpinigaitis PV. (2006). Current and future peripherally-acting antitussives. Respir Physiol Neurobiol 152:356–62.
- Genovese CR. (2015). False discovery rate control. Brain Mapp 1:501–7.
- Han J, Lv QY, Jin SY, et al. (2014). Comparison of anti-bacterial activity of three types of di-O-caffeoylquinic acids in Lonicera japonica flowers based on microcalorimetry. Chin J Nat Med 12:0108–13.
- Han N, Chang CL, Wang YC, et al. (2010). The in vivo expectorant and antitussive activity of extract and fractions from Reineckia carnea. J Ethnopharmacol 131:220–3.
- Jiang K, Song Q, Wang L, et al. (2014). Antitussive, expectorant and anti-inflammatory activities of different extracts from exocarpium Citri grandis. J Ethnopharmacol 156:97–101.
- Kamei J. (2002). Delta-opioid receptor antagonists as a new concept for central acting antitussive drugs. Pulm Pharmacol Ther 15:235–40.
- Kim KH, Kim YH, Lee RK. (2007). Isolation of quinic acid derivatives and flavonoids from the aerial parts of Lactuca indica L. and their hepatoprotective activity in vitro. Bioorg Med Chem Lett 17:6739–43.
- Li C, Huang F, Dou CG, et al. (2009a). Anti-inflammatory activity of Radix Asteris and Flos Farfarae in drug combination. Chin J Clin Pharmacol Ther 14:155–8.
- Li N, Ma SP, Huang F, et al. (2009b). Research on combination of the Radix Asteris with Flos Farfarae and the effect of Radix Asteris for expectorant. Chin J Clin Pharmacol Ther 14:159–62.
- Li Y, But PP, Ooi VE. (2005). Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Frodin. Antivir Res 68:1–9.
- Li ZY, Zhi HJ, Zhang FS, et al. (2013). Metabolomic profiling of the antitussive and expectorant plant Tussilago farfara L. by nuclear magnetic resonance spectroscopy and multivariate data analysis. J Pharm Biomed 75:158–64.
- Liu YF, Yang XW, Wu B. (2007). Chemical constituents of the flower buds of Tussilago farfara. J Chin Pharm Sci 16:288–93.
- Mackenzie AJ, Spina D, Page CP. (2004). Models used in the development of antitussive drugs. Drug Discov Today 1:297–302.
- Nanjing University of Chinese Medicine. (2006). The Dictionary of Medicinal Plant (2nd ed). Shanghai: Shanghai Scientific and Technical Publishers.
- Niimi A. (2013). Cough, asthma, and cysteinyl-leukotrienes. Pulm Pharmacol Ther 26:514–19.
- Reynolds SM, Mackenzie AJ, Spina D, et al. (2004). The pharmacology of cough. Trends Pharmacol Sci 25:569–76.
- Shan JH, Fu J, Zhao ZH, et al. (2009). Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-κB and JNK/AP-1 activation. Int Immunopharmacol 9:1042–8.
- Wang DD, Wang S, Chen X, et al. (2012). Antitussive, expectorant and anti-inflammatory activities of four alkaloids isolated from bulbus of Fritillaria wabuensis. J Ethnopharmacol 139:189–93.
- Wang L. (2013). Studies on the antitussive part of the flower buds of Tussilago farfara [Master’s thesis]. China Pharmaceutical University.
- Wei W, Wu XM, Li YJ. (2010). Methodology of Pharmacological Experiment (4th ed). Beijing: People's Medical Publishing House.
- Xue SY, Li ZY, Zhi HJ, et al. (2012). Metabolic fingerprinting investigation of Tussilago farfara L. by GC-MS and multivariate data analysis. Biochem Syst Ecol 41:6–12.
- Young EC, Smith JA. (2011). Pharmacologic therapy for cough. Curr Opin Pharmacol 11:224–30.
- Zhang QZ, Zhang Y, Zhang M, et al. (2009). Antitussive part of Flos Farfarae and potentiating part of Radix Asteris in pair-drug of FTF and RA. Lishizhen Med Mater Med Res 20:1042–4.